AU2018344573B2 - Biomarker - Google Patents

Biomarker Download PDF

Info

Publication number
AU2018344573B2
AU2018344573B2 AU2018344573A AU2018344573A AU2018344573B2 AU 2018344573 B2 AU2018344573 B2 AU 2018344573B2 AU 2018344573 A AU2018344573 A AU 2018344573A AU 2018344573 A AU2018344573 A AU 2018344573A AU 2018344573 B2 AU2018344573 B2 AU 2018344573B2
Authority
AU
Australia
Prior art keywords
chromosome
interactions
probe
disease
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018344573A
Other languages
English (en)
Other versions
AU2018344573A1 (en
Inventor
Alexandre Akoulitchev
Ewan HUNTER
Aroul Selvam Ramadass
Matthew SALTER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biodynamics PLC
Original Assignee
Oxford Biodynamics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biodynamics PLC filed Critical Oxford Biodynamics PLC
Publication of AU2018344573A1 publication Critical patent/AU2018344573A1/en
Assigned to Oxford BioDynamics PLC reassignment Oxford BioDynamics PLC Amend patent request/document other than specification (104) Assignors: OXFORD BIODYNAMICS LIMITED
Application granted granted Critical
Publication of AU2018344573B2 publication Critical patent/AU2018344573B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2018344573A 2017-10-02 2018-10-01 Biomarker Active AU2018344573B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762566756P 2017-10-02 2017-10-02
US62/566,756 2017-10-02
PCT/GB2018/052808 WO2019069067A1 (en) 2017-10-02 2018-10-01 BIOMARKER

Publications (2)

Publication Number Publication Date
AU2018344573A1 AU2018344573A1 (en) 2020-04-09
AU2018344573B2 true AU2018344573B2 (en) 2020-09-17

Family

ID=63834322

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018344573A Active AU2018344573B2 (en) 2017-10-02 2018-10-01 Biomarker

Country Status (11)

Country Link
US (1) US12006547B2 (enExample)
EP (1) EP3692168A1 (enExample)
JP (2) JP2020537514A (enExample)
KR (1) KR102762920B1 (enExample)
CN (1) CN111344415B (enExample)
AU (1) AU2018344573B2 (enExample)
CA (1) CA3076450A1 (enExample)
MY (1) MY200184A (enExample)
SG (1) SG11202002503TA (enExample)
WO (1) WO2019069067A1 (enExample)
ZA (1) ZA202001821B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3152645A1 (en) * 2019-09-11 2021-03-18 Oxford BioDynamics PLC Diagnostic chromosome marker
GB202016176D0 (en) * 2020-10-12 2020-11-25 Oxford BioDynamics PLC Disease marker
EP4274910A1 (en) * 2021-01-07 2023-11-15 Oxford BioDynamics PLC Chromosome interactions
CN113035298B (zh) * 2021-04-02 2023-06-20 南京信息工程大学 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116280A1 (en) * 1993-03-05 1994-09-06 Marcy E. Macdonald Huntingtin dna, protein and uses thereof
NZ564262A (en) * 2005-07-04 2010-02-26 Univ Erasmus Medical Ct Chromosome conformation capture-on-chip (4C) assay
GB0810051D0 (en) 2008-06-02 2008-07-09 Oxford Biodynamics Ltd Method of diagnosis
JP5503942B2 (ja) * 2009-10-30 2014-05-28 シスメックス株式会社 疾患の罹患の判定方法
EP2710146A2 (en) * 2011-05-18 2014-03-26 Life Technologies Corporation Chromosome conformation analysis
JP2018518203A (ja) 2015-06-24 2018-07-12 オックスフォード バイオダイナミックス リミテッド エピジェネティックな染色体相互作用
WO2017001568A1 (en) * 2015-07-01 2017-01-05 Universitat De Lleida Treatment and prevention of amyotrophic lateral sclerosis
MY191260A (en) 2016-12-23 2022-06-12 Oxford BioDynamics PLC Typing method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
C R Lim ET AL, (2017-09-21), URL: https://www.oxfordbiodynamics.com/wp-content/uploads/2016/10/ALSposter_WCN2017Kyoto_Final.pdf, (2018-12-13) *

Also Published As

Publication number Publication date
KR102762920B1 (ko) 2025-02-04
WO2019069067A1 (en) 2019-04-11
KR20200058527A (ko) 2020-05-27
SG11202002503TA (en) 2020-04-29
ZA202001821B (en) 2022-10-26
AU2018344573A1 (en) 2020-04-09
MY200184A (en) 2023-12-12
NZ762713A (en) 2025-03-28
JP2023182591A (ja) 2023-12-26
US12006547B2 (en) 2024-06-11
JP7701419B2 (ja) 2025-07-01
CN111344415A (zh) 2020-06-26
JP2020537514A (ja) 2020-12-24
US20200407790A1 (en) 2020-12-31
CA3076450A1 (en) 2019-04-11
EP3692168A1 (en) 2020-08-12
CN111344415B (zh) 2024-04-30

Similar Documents

Publication Publication Date Title
JP7701419B2 (ja) バイオマーカー
JP7631400B2 (ja) 遺伝子調節
JP2025108590A (ja) 診断用染色体マーカー
US11535893B2 (en) Typing method
WO2022148957A1 (en) Chromosome interactions
KR20230019939A (ko) 섬유증, 예를 들어 경피증에 대한 마커로서의 염색체 형태 검출
JPWO2019069067A5 (enExample)
WO2022079418A1 (en) Disease marker
HK40031541A (en) Biomarker
HK40031541B (zh) 生物标志物
HK40017704B (en) Typing method for the diagnosis of alzheimer's disease
HK40017704A (en) Typing method for the diagnosis of alzheimer's disease

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: OXFORD BIODYNAMICS PLC

Free format text: FORMER NAME(S): OXFORD BIODYNAMICS LIMITED

FGA Letters patent sealed or granted (standard patent)